Oruka Therapeutics Market Cap

Oruka Therapeutics has a market cap or net worth of $359.43 million as of May 9, 2025. Its market cap has increased by 618.86% in one year.

Market Cap

359.43M

Enterprise Value

-27.70M

1-Year Change

618.86%

Ranking

#3154

Market Cap Chart

Since December 1, 1998, Oruka Therapeutics's market cap has increased from $63.80M to $359.43M, an increase of 463.37%. That is a compound annual growth rate of 6.75%.

Market Cap History

Date	Market Cap	% Change
May 7, 2025	357.20M	-47.36%
Dec 31, 2024	678.60M	2,669.80%
Dec 29, 2023	24.50M	-28.36%
Dec 30, 2022	34.20M	10.32%
Dec 31, 2021	31.00M	-17.11%
Dec 31, 2020	37.40M	310.99%
Dec 31, 2019	9.10M	97.83%
Dec 31, 2018	4.60M	-71.07%
Dec 29, 2017	15.90M	-38.61%
Dec 30, 2016	25.90M	-38.48%
Dec 31, 2015	42.10M	108.42%
Dec 31, 2014	20.20M	-23.19%
Dec 31, 2013	26.30M	345.76%
Dec 31, 2012	5.90M	-43.81%
Dec 30, 2011	10.50M	-62.50%
Dec 31, 2010	28.00M	12.90%
Dec 31, 2009	24.80M	49.40%
Dec 31, 2008	16.60M	-82.99%
Dec 31, 2007	97.60M	-53.94%
Dec 29, 2006	211.90M	-38.20%
Dec 30, 2005	342.90M	7.80%
Dec 31, 2004	318.10M	19.27%
Dec 31, 2003	266.70M	1,240.20%
Dec 31, 2002	19.90M	-86.49%
Dec 31, 2001	147.30M	-24.77%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	695.85B
Johnson & Johnson	371.67B
UnitedHealth Group	359.09B
AbbVie	331.06B
Novo Nordisk	297.73B
Abbott Laboratories	231.50B
AstraZeneca	221.83B
Novartis AG	220.92B

Market Cap Rankings